https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder
0
0
5/23/23 at 7:00pm
Organization
FDA.gov
Author
Office of the Commissioner
30 words
0
Comments
The U.S. Food and Drug Administration approved Brixadi to treat moderate to severe opioid use disorder (OUD).
You are the first to view
Create an account
or login to join the discussion